quinoxalines has been researched along with bumetanide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ben-Ari, Y; Holmes, GL; Ivanov, A; Khazipov, R; Minlebaev, M; Represa, A; Rheims, S; Zilberter, Y | 1 |
| Arisi, I; Brandi, R; Capsoni, S; Cattaneo, A; Cherubini, E; D'Onofrio, M; Franzot, J; Lagostena, L; Rosato-Siri, M | 1 |
2 other study(ies) available for quinoxalines and bumetanide
| Article | Year |
|---|---|
Excitatory GABA in rodent developing neocortex in vitro.
Topics: Age Factors; Animals; Animals, Newborn; Bumetanide; Excitatory Amino Acid Antagonists; Female; GABA Agents; gamma-Aminobutyric Acid; In Vitro Techniques; Interneurons; Lysine; Male; Membrane Potentials; Mice; Models, Neurological; Neocortex; Patch-Clamp Techniques; Pyramidal Cells; Quinoxalines; Sodium Potassium Chloride Symporter Inhibitors; Valine | 2008 |
In the adult hippocampus, chronic nerve growth factor deprivation shifts GABAergic signaling from the hyperpolarizing to the depolarizing direction.
Topics: 2-Amino-5-phosphonovalerate; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Antibodies, Neutralizing; Biophysics; Bumetanide; Electric Stimulation; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABA Agonists; GABA Antagonists; gamma-Aminobutyric Acid; Gene Expression Regulation; Hippocampus; In Vitro Techniques; Ion Channel Gating; Isonicotinic Acids; K Cl- Cotransporters; Mice; Mice, Transgenic; Nerve Growth Factor; Neurons; Patch-Clamp Techniques; Pyridazines; Quinoxalines; Receptors, Nicotinic; RNA, Messenger; Sodium Potassium Chloride Symporter Inhibitors; Symporters | 2010 |